{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:59:36Z","timestamp":1758052776462,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.clinbiochem.2011.08.1146","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T07:46:49Z","timestamp":1315900009000},"page":"203-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population"],"prefix":"10.1016","volume":"45","author":[{"given":"Zaixing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renqian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1089-3261(03)00104-1","article-title":"Antimitochondrial and other autoantibodies","volume":"7","author":"Bogdanos","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.2003.07270.x","article-title":"Positive markers in AMA-negative PBC","volume":"98","author":"Vergani","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0015","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.21828","article-title":"Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis","volume":"46","author":"Leung","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0020","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/hep.22179","article-title":"Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience","volume":"47","author":"Bernal","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","author":"Montano-Loza","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1146_bb0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00004836-200201000-00022","article-title":"Acute cholestatic hepatitis caused by Teucrium polium (golden germander) with transient appearance of antimitochondrial antibody","volume":"34","author":"Polymeros","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0040","first-page":"1123","article-title":"Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis","volume":"26","author":"Zuchner","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(00)00040-4","article-title":"Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis","volume":"34","author":"Invernizzi","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0060","first-page":"291","article-title":"American Association for Study of Liver Diseases","volume":"50","author":"Lindor","year":"2009","journal-title":"Primary biliary cirrhosis. Hepatology"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2009.08.009","article-title":"A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis","volume":"34","author":"Agmon-Levin","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0070","article-title":"Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis","author":"Hu","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","article-title":"Performance parameters of the conventional serological markers for autoimmune hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0080","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0085","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","article-title":"Autoantibodies in liver disease","volume":"120","author":"Czaja","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0095","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cca.2010.12.019","article-title":"Disease-specific autoantibodies in primary biliary cirrhosis","volume":"412","author":"Bogdanos","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0896-8411(03)00084-2","article-title":"Low frequency of anti-SLA\/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay","volume":"21","author":"Miyakawa","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0105","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardized SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0115","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-A\u2044Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0120","first-page":"1404","article-title":"Differential recognition of the 52-kd Ro(SS-A) antigen by sera from patients with primary biliary cirrhosis and primary Sjogren's syndrome","volume":"24","author":"Dorner","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00002512-200825030-00005","article-title":"Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly","volume":"25","author":"Czaja","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0130","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2002.05921.x","article-title":"Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clinbiochem.2011.08.1146_bb0135","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10620-006-9109-7","article-title":"Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease","volume":"52","author":"Banks","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.clinbiochem.2011.08.1146_bb0140","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0145","first-page":"171","article-title":"Transient detection of antinuclear and anti-smooth muscle antibodies in hepatitis A virus infection","volume":"90","author":"Gutierrez","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1146_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8278(96)80197-8","article-title":"Transient positivity of antinuclear and anti-smooth muscle antibodies in hepatitis A virus infection","volume":"24","author":"Gutierrez","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinbiochem.2011.08.1146_bb0155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011026348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011026348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:38:00Z","timestamp":1757864280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912011026348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0009912011026348"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.08.1146","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.08.1146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}